These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 29975703)

  • 1. Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.
    Jeong DH; Kang J; Jung YJ; Yoo B; Lee CK; Kim YG; Hong S; Shim TS; Jo KW
    PLoS One; 2018; 13(7):e0198756. PubMed ID: 29975703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
    Calzada-Hernández J; Anton J; Martín de Carpi J; López-Montesinos B; Calvo I; Donat E; Núñez E; Blasco Alonso J; Mellado MJ; Baquero-Artigao F; Leis R; Vegas-Álvarez AM; Medrano San Ildefonso M; Pinedo-Gago MDC; Eizaguirre FJ; Tagarro A; Camacho-Lovillo M; Pérez-Gorricho B; Gavilán-Martín C; Guillén S; Sevilla-Pérez B; Peña-Quintana L; Mesa-Del-Castillo P; Fortuny C; Tebruegge M; Noguera-Julian A
    Eur J Pediatr; 2023 Jan; 182(1):307-317. PubMed ID: 36335186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QuantiFERON-TB Gold In-Tube assay for screening arthritis patients for latent tuberculosis infection before starting anti-tumor necrosis factor treatment.
    Lee H; Park HY; Jeon K; Jeong BH; Hwang JW; Lee J; Cha HS; Koh EM; Kang ES; Koh WJ
    PLoS One; 2015; 10(3):e0119260. PubMed ID: 25746854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea.
    Chang B; Park HY; Jeon K; Ahn JK; Cha HS; Koh EM; Kang ES; Koh WJ
    Clin Rheumatol; 2011 Dec; 30(12):1535-41. PubMed ID: 21556777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
    Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
    Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
    Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
    Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
    Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
    Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
    Hsia EC; Schluger N; Cush JJ; Chaisson RE; Matteson EL; Xu S; Beutler A; Doyle MK; Hsu B; Rahman MU
    Arthritis Rheum; 2012 Jul; 64(7):2068-77. PubMed ID: 22238071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic review: agreement between the latent tuberculosis screening tests among patients with rheumatic diseases.
    Pyo J; Cho SK; Kim D; Sung YK
    Korean J Intern Med; 2018 Nov; 33(6):1241-1251. PubMed ID: 29277097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QuantiFERON-TB Gold In-Tube Test in the Diagnosis of Latent Tuberculosis Infection in Arthritis Patients Treated with Tumor Necrosis Factor Antagonists.
    Baričević D; Popović Grle S; Morović Vergles J; Čuković Čavka S; Jakopović M; Redžepi G; Boras Z; Baričević M; Samaržija M
    Acta Clin Croat; 2017 Jun; 56(2):203-209. PubMed ID: 29485786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
    Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES
    PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
    Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
    J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy.
    Mariette X; Baron G; Tubach F; Lioté F; Combe B; Miceli-Richard C; Flipo RM; Goupille P; Allez M; Salmon D; Emilie D; Carcelain G; Ravaud P
    Ann Rheum Dis; 2012 Nov; 71(11):1783-90. PubMed ID: 22258485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis of tuberculin skin test and the QuantiFERON-TB Gold In-tube test for tuberculosis screening in a correctional setting in Dallas, Texas, USA.
    Nijhawan AE; Iroh PA; Brown LS; Winetsky D; Porsa E
    BMC Infect Dis; 2016 Oct; 16(1):564. PubMed ID: 27733123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the tuberculin skin test and interferon-γ release assay for the diagnosis of latent tuberculosis infection before kidney transplantation.
    Kim SY; Jung GS; Kim SK; Chang J; Kim MS; Kim YS; Kang YA; Joo DJ
    Infection; 2013 Feb; 41(1):103-10. PubMed ID: 22802098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients.
    Ryu MR; Park MS; Cho EH; Jung CW; Kim K; Kim SJ; Oh HY; Huh W; Jang HR; Koh WJ; Park HY; Kim YH; Sinn DH; Choi JO; Joh JW; Kim JM; Kim SJ; Park JB; Kang ES
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland.
    Kruczak K; Duplaga M; Sanak M; Cmiel A; Mastalerz L; Sladek K; Nizankowska-Mogilnicka E
    Scand J Infect Dis; 2014 Sep; 46(9):649-55. PubMed ID: 25073535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantiferon TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents.
    Klein M; Jarosová K; Forejtová S; Bečvář R; Sedová L; Pavelka K; Simková G; Svobodová R; Hviscová K; Mann H; Půtová I; Vencovský J
    Clin Exp Rheumatol; 2013; 31(1):111-7. PubMed ID: 23101473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.
    Bukhary ZA; Amer SM; Emara MM; Abdalla ME; Ali SA
    Ann Saudi Med; 2018; 38(2):90-96. PubMed ID: 29620541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.